mTOR: from growth signal integration to cancer, diabetes and ageing.

mTOR: from growth signal integration to cancer, diabetes and ageing.
复制标题

DOI:
10.1038/nrm3025
复制
发表时间:
2011-01
期刊:
Nature reviews. Molecular cell biology
影响因子:
--
通讯作者:
--
中科院分区:
其他
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

在所有真核生物中,雷帕霉素(TOR)信号通路的靶点将能量和营养丰度与细胞生长和分裂的执行相耦合,这是由于TOR蛋白激酶能够同时感测能量、营养和应激,以及在后生动物中感测生长因子。哺乳动物TOR复合物1和2(mTORC 1和mTORC 2)通过调节其他重要激酶(如S6K和Akt)发挥作用。在过去的几年中,我们对mTOR的调节和功能的理解取得了重大进展,揭示了它在糖尿病,癌症和衰老的发病和进展中的重要作用。
In all eukaryotes, the target of rapamycin (TOR) signaling pathway couples energy and nutrient abundance to the execution of cell growth and division, owing to the ability of TOR protein kinase to simultaneously sense energy, nutrients and stress, and, in metazoan, growth factors. Mammalian TOR complexes 1 and 2 (mTORC1 and mTORC2) exert their actions by regulating other important kinases, such as S6K and Akt. In the last few years, a significant advance in our understanding of the regulation and functions of mTOR has revealed its critical involvement in the onset and progression of diabetes, cancer and ageing.
DOI: 10.1016/j.molcel.2005.05.020
发表时间: 2005-07-01
期刊: MOLECULAR CELL
影响因子: 16
作者:
Dubouloz, F;Deloche, O;De Virgillo, C
通讯作者: De Virgillo, C
有效使用 PI3K 和 MEK 抑制剂治疗突变型 Kras G12D 和 PIK3CA H1047R 小鼠肺癌。
DOI: 10.1038/nm.1890
发表时间: 2008-12
期刊: Nature medicine
影响因子: 82.9
作者:
通讯作者: --
DOI: 10.1038/nature06322
发表时间: 2007-11-29
期刊: NATURE
影响因子: 64.8
作者:
Cunningham, John T.;Rodgers, Joseph T.;Puigserver, Pere
通讯作者: Puigserver, Pere
DOI: 10.1126/science.1124147
发表时间: 2006-05-12
期刊: SCIENCE
影响因子: 56.9
作者:
Cota, D;Proulx, K;Seeley, RJ
通讯作者: Seeley, RJ
DOI: 10.1126/science.1063518
发表时间: 2001-11-02
期刊: SCIENCE
影响因子: 56.9
作者:
Dennis, PB;Jaeschke, A;Thomas, G
通讯作者: Thomas, G